Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
2.920
+0.420 (16.80%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.18 million as of June 26, 2026. Its market cap has decreased by -33.30% in one year.
Market Cap
2.18M
Enterprise Value
-9.23M
1-Year Change
-33.30%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $2.18M, a decrease of -97.87%. That is a compound annual growth rate of -40.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.18M | 14.42% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Green Med Solution | 3.32M |
| Decoy Therapeutics | 3.15M |
| VivoSim Labs | 3.10M |
| Calidi Biotherapeutics | 2.92M |
| Azitra | 2.68M |
| Oragenics | 2.58M |
| Bone Biologics | 2.41M |
| Valion Bio | 1.85M |